QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
NASDAQ:MTAC

MedTech Acquisition Short Interest Ratio and Short Volume

$9.90
-0.03 (-0.30 %)
(As of 09/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.85
$9.90
50-Day Range
$9.66
$9.93
52-Week Range
$9.45
$11.18
Volume31,479 shs
Average Volume78,764 shs
Market Capitalization$309.38 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

MedTech Acquisition (NASDAQ:MTAC) Short Interest Data

Current Short Volume858,700 shares
Previous Short Volume19,700 shares
Change Vs. Previous Month+4,258.88%
Dollar Volume Sold Short$8.44 million
Short Interest Ratio / Days to Cover8.0
Last Record DateAugust, 31 2021
Outstanding Shares31,250,000 shares
Percentage of Shares Shorted2.75%
Today's Trading Volume31,479 shares
Average Trading Volume78,764 shares
Today's Volume Vs. Average-60.03%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling MedTech Acquisition ?

Sign up to receive the latest short interest report for MedTech Acquisition and its competitors with MarketBeat's FREE newsletter.

MedTech Acquisition (NASDAQ:MTAC) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/2021858,700 shares $8.44 million +4,258.9%N/A8 $9.83
8/13/202119,700 shares $194,636.00 No ChangeN/A0.2 $9.88

MedTech Acquisition (NASDAQ:MTAC) Short Interest FAQ

speech bubbles
speech bubbles











MedTech Acquisition (NASDAQ:MTAC) Short Interest Frequently Asked Questions

What is MedTech Acquisition's current short interest?

Short interest is the volume of MedTech Acquisition shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 858,700 shares of MTAC short. Learn More on MedTech Acquisition's current short interest.

What is a good short interest ratio for MedTech Acquisition?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MedTech Acquisition currently has a short interest ratio of 8.0. Learn More on a good short interest ratio for MedTech Acquisition

Is MedTech Acquisition's short interest increasing or decreasing?

MedTech Acquisition saw a increase in short interest in August. As of August 31st, there was short interest totaling 858,700 shares, an increase of 4,258.9% from the previous total of 19,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does MedTech Acquisition's short interest compare to its competitors?

0.00% of MedTech Acquisition's shares are currently sold short. Here is how the short interest of companies in the industry of "holding & other investment offices" compare to MedTech Acquisition: Ares Acquisition Co. (0.10%), FTAC Hera Acquisition Corp. (0.05%), Compute Health Acquisition Corp. (0.08%), Gores Guggenheim, Inc. (0.49%), Brooge Energy Limited (0.27%), Cohn Robbins Holdings Corp. (0.39%), Apollo Strategic Growth Capital (0.16%), Bain Capital Specialty Finance, Inc. (0.32%), CONX Corp. (0.23%), and Apollo Strategic Growth Capital II (0.07%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short MedTech Acquisition stock?

Short selling MTAC is an investing strategy that aims to generate trading profit from MedTech Acquisition as its price is falling. MedTech Acquisition's stock is trading down $0.03 today. To short MedTech Acquisition stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that MedTech Acquisition will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against MedTech Acquisition?

A short squeeze for MedTech Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MTAC, which in turn drives the price of the stock up even further.

How often is MedTech Acquisition's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTAC, twice per month. The most recent reporting period available is August, 31 2021.



This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.